Phenome-wide association study using research participants' self-reported data provides insight into the Th17 and IL-17 pathway

A phenome-wide association study of variants in genes in the Th17 and IL-17 pathway was performed using self-reported phenotypes and genetic data from 521,000 research participants of 23andMe. Results replicated known associations with similar effect sizes for autoimmune traits illustrating self-rep...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 12; no. 11; p. e0186405
Main Authors: Ehm, Margaret G, Aponte, Jennifer L, Chiano, Mathias N, Yerges-Armstrong, Laura M, Johnson, Toby, Barker, Jonathan N, Cook, Suzanne F, Gupta, Akanksha, Hinds, David A, Li, Li, Nelson, Matthew R, Simpson, Michael A, Tian, Chao, McCarthy, Linda C, Rajpal, Deepak K, Waterworth, Dawn M
Format: Journal Article
Language:English
Published: United States Public Library of Science 01-11-2017
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A phenome-wide association study of variants in genes in the Th17 and IL-17 pathway was performed using self-reported phenotypes and genetic data from 521,000 research participants of 23andMe. Results replicated known associations with similar effect sizes for autoimmune traits illustrating self-reported traits can be a surrogate for clinically assessed conditions. Novel associations controlling for a false discovery rate of 5% included the association of the variant encoding p.Ile684Ser in TYK2 with increased risk of tonsillectomy, strep throat occurrences and teen acne, the variant encoding p.Arg381Gln in IL23R with a decrease in dandruff frequency, the variant encoding p.Asp10Asn in TRAF3IP2 with risk of male-pattern balding, and the RORC regulatory variant (rs4845604) with protection from allergies. This approach enabled rapid assessment of association with a wide variety of traits and investigation of traits with limited reported associations to overlay meaningful phenotypic context on the range of conditions being considered for drugs targeting this pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: Margaret G. Ehm, Mathias N. Chiano, Laura M. Yerges-Armstrong, Toby Johnson, Akanksha Gupta, Matthew R. Nelson, Linda C. McCarthy, Deepak K. Rajpal, and Dawn M. Waterworth are employed by GlaxoSmithKline and may be stockholders of GlaxoSmithKline. Jennifer L. Aponte, Li Li and Suzanne F. Cook were employed by GlaxoSmithKline during the term of the research project and may own GlaxoSmithKline stock. Jennifer L. Aponte is an employee of PAREXEL International. David A. Hinds and Chao Tian are employed by 23andMe and own stock or stock options in 23andMe. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0186405